Showing 1 - 7 results of 7 for search 'Boni Elewski', query time: 0.03s Refine Results
  1. 1
    Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials

    Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials by Boni Elewski, Phoebe Rich, Edward Lain, Jennifer Soung, George Michael Lewitt, Abby Jacobson

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographic

    Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographic by Jennifer Bares, BS, Apphia Wang, MD, Peter Pavlidakey, MD, Diego De Idiaquez Bakula, MD, Boni Elewski, MD

    Published 2017-01-01
    Get full text
    Article
  3. 3
    Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis

    Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis by Boni Elewski, Alan Menter, Jeffrey Crowley, Stephen Tyring, Yang Zhao, Simon Lowry, Stephen Rozzo, Alan M. Mendelsohn, Jeffrey Parno, Kenneth Gordon

    Published 2020-11-01
    Get full text
    Article
  4. 4
    Concerning rates of laboratory‐confirmed antifungal‐resistant onychomycosis and tinea pedis: An online survey of podiatrists, United States

    Concerning rates of laboratory‐confirmed antifungal‐resistant onychomycosis and tinea pedis: An online survey of podiatrists, United States by Kaitlin Benedict, Jeremy A. W. Gold, Carolynn T. Jones, Lisa A. Tushla, Shari R. Lipner, Warren S. Joseph, Dyane E. Tower, Boni Elewski, Peter G. Pappas

    Published 2023-11-01
    Get full text
    Article
  5. 5
    Improving antifungal stewardship in dermatology in an era of emerging dermatophyte resistance

    Improving antifungal stewardship in dermatology in an era of emerging dermatophyte resistance by Avrom S. Caplan, MD, Jeremy A.W. Gold, MD, MS, Dallas J. Smith, PharmD, MAS, Shari R. Lipner, MD, PhD, Peter G. Pappas, MD, Boni Elewski, MD

    Published 2024-06-01
    Get full text
    Article
  6. 6
    Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)

    Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Stu... by Paolo Gisondi, Alice B. Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M. López Pinto, Nicola Tilt, Mark Lebwohl

    Published 2023-05-01
    Get full text
    Article
  7. 7
    Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)

    Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CI... by Paolo Gisondi, Alice B. Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M. López Pinto, Nicola Tilt, Mark Lebwohl

    Published 2022-12-01
    Get full text
    Article

Search Tools: